News

Five-day dosing regimen for Dacogen approved for myelodysplastic syndromes (MDS)

March 12, 2010

The FDA has approved a five-day dosing regimen for Dacogen (decitabine for injection, from Eisai) to treat patients with myelodysplastic syndromes (MDS).
 

Trelstar 22.5mg approved for palliative treatment of prostate cancer

March 11, 2010

The FDA has approved Trelstar 22.5mg (triptorelin pamoate for injectable suspension, from Watson) for the palliative treatment of advanced prostate cancer.
 

Botox approved for upper limb spasticity

March 10, 2010

The FDA has approved Botox (onabotulinumtoxin A, from Allergan) for the treatment of spasticity in the flexor muscles of the elbow, wrist, and fingers in adults.
 

Pediaderm HC Complete Kit available for atopic dermatitis

March 09, 2010

Arbor Pharmaceuticals announced the launch of Pediaderm HC Complete Kit which contains Pediaderm HC (hydrocortisone lotion 2%) and nonsteroidal Pediaderm Protective Emollient with Triple Synergy Technology.
 

Generic timolol maleate ophthalmic gel forming solution available

March 09, 2010

Aton Pharma announced the availability of an authorized generic version of its Timoptic-XE (timolol maleate ophthalmic gel forming solution).
 

Xiaflex available for Dupuytren's contracture

March 08, 2010

BioSpecifics Technologies and Auxilium Pharmaceuticals announced the availability of Xiaflex (collagenase clostridium histolyticum) for the treatment of adult Dupuytren's contracture patients with a palpable cord.
 

Hizentra approved for primary immunodeficiency

March 05, 2010

The FDA has approved CSL Behring's Hizentra (immune globulin [human] 20% liquid for subcutaneous injection) for the once weekly treatment of primary immunodeficiency.
 

Kapidex to be marketed under new trade name Dexilant

March 04, 2010

Takeda Pharmaceuticals announced that Kapidex (dexlansoprazole delayed-release capsules) will now be marketed under a new product trade name, Dexilant, due to reports of dispensing errors.
 

Norditropin FlexPro pen approved for growth hormone treatment

March 03, 2010

The FDA has approved Norditropin FlexPro (somatropin [rDNA origin] injection, from Novo Nordisk), a pre-filled injection pen, for patients with growth hormone disorders.
 

Generic tamsulosin available for benign prostatic hyperplasia (BPH)

March 03, 2010

The FDA has approved a generic version of Flomax (tamsulosin HCl capsules, from Boehringer Ingelheim) for the treatment of benign prostatic hyperplasia (BPH).
 

Download the MPR Mobile & Desktop Edition for free access to over 4,000 up-to-date, concise drug monographs on your computer or mobile device.

Job Search


Take our Feedback Survey

Tell us what you think & take our survey!

MPR Poll

Have a clinical question?

Doctors with clinical questions get them answered here by our panel of consultants. We also welcome your comments or short pearls of clinical wisdom. Submit your questions or e-mail your comments to us and we guarantee you a response
 Subscribe to the RSS for this page  [view all our RSS feeds here]